ACQUIREDT+2Regeneron Pharmaceuticals · NASDAQ+6,283 sh · $2.4MFiled 20 Aug 2026·SEC Form 4·view source
REDUCEDT+2Regeneron Pharmaceuticals · NASDAQ−4,599 sh · $3.7MFiled 20 Aug 2026·SEC Form 4·view source